Drug Eluting Balloon Catheters Market Report – Research, Industry Analysis Reports and Market Demands

Global Drug Eluting Balloon Catheters Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Drug Eluting Balloon Catheters Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Peripheral DEB
- 1.3.3 Coronary DEB
1.4 Market Analysis by Balloon Platform Mechanics
- 1.4.1 Overview: Global Drug Eluting Balloon Catheters Consumption Value by Balloon Platform Mechanics: 2021 Versus 2025 Versus 2032
- 1.4.2 In-Stent Restenosi
- 1.4.3 De Novo
- 1.4.4 Small Vessel
1.5 Market Analysis by Application
- 1.5.1 Overview: Global Drug Eluting Balloon Catheters Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Cardiac Catheterization Lab
- 1.5.3 Hospital
- 1.5.4 Other
1.6 Global Drug Eluting Balloon Catheters Market Size & Forecast
- 1.6.1 Global Drug Eluting Balloon Catheters Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Drug Eluting Balloon Catheters Sales Quantity (2021-2032)
- 1.6.3 Global Drug Eluting Balloon Catheters Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Drug Eluting Balloon Catheters by Manufacturer

3.1 Global Drug Eluting Balloon Catheters Sales Quantity by Manufacturer (2021-2026)
3.2 Global Drug Eluting Balloon Catheters Revenue by Manufacturer (2021-2026)
3.3 Global Drug Eluting Balloon Catheters Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Drug Eluting Balloon Catheters by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Drug Eluting Balloon Catheters Manufacturer Market Share in 2025
- 3.4.3 Top 6 Drug Eluting Balloon Catheters Manufacturer Market Share in 2025
3.5 Drug Eluting Balloon Catheters Market: Overall Company Footprint Analysis
- 3.5.1 Drug Eluting Balloon Catheters Market: Region Footprint
- 3.5.2 Drug Eluting Balloon Catheters Market: Company Product Type Footprint
- 3.5.3 Drug Eluting Balloon Catheters Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Drug Eluting Balloon Catheters Market Size by Region
- 4.1.1 Global Drug Eluting Balloon Catheters Sales Quantity by Region (2021-2032)
- 4.1.2 Global Drug Eluting Balloon Catheters Consumption Value by Region (2021-2032)
- 4.1.3 Global Drug Eluting Balloon Catheters Average Price by Region (2021-2032)
4.2 North America Drug Eluting Balloon Catheters Consumption Value (2021-2032)
4.3 Europe Drug Eluting Balloon Catheters Consumption Value (2021-2032)
4.4 Asia-Pacific Drug Eluting Balloon Catheters Consumption Value (2021-2032)
4.5 South America Drug Eluting Balloon Catheters Consumption Value (2021-2032)
4.6 Middle East & Africa Drug Eluting Balloon Catheters Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Drug Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
5.2 Global Drug Eluting Balloon Catheters Consumption Value by Type (2021-2032)
5.3 Global Drug Eluting Balloon Catheters Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Drug Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
6.2 Global Drug Eluting Balloon Catheters Consumption Value by Application (2021-2032)
6.3 Global Drug Eluting Balloon Catheters Average Price by Application (2021-2032)

7 North America

7.1 North America Drug Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
7.2 North America Drug Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
7.3 North America Drug Eluting Balloon Catheters Market Size by Country
- 7.3.1 North America Drug Eluting Balloon Catheters Sales Quantity by Country (2021-2032)
- 7.3.2 North America Drug Eluting Balloon Catheters Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Drug Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
8.2 Europe Drug Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
8.3 Europe Drug Eluting Balloon Catheters Market Size by Country
- 8.3.1 Europe Drug Eluting Balloon Catheters Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Drug Eluting Balloon Catheters Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Drug Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Drug Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Drug Eluting Balloon Catheters Market Size by Region
- 9.3.1 Asia-Pacific Drug Eluting Balloon Catheters Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Drug Eluting Balloon Catheters Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Drug Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
10.2 South America Drug Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
10.3 South America Drug Eluting Balloon Catheters Market Size by Country
- 10.3.1 South America Drug Eluting Balloon Catheters Sales Quantity by Country (2021-2032)
- 10.3.2 South America Drug Eluting Balloon Catheters Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Drug Eluting Balloon Catheters Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Drug Eluting Balloon Catheters Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Drug Eluting Balloon Catheters Market Size by Country
- 11.3.1 Middle East & Africa Drug Eluting Balloon Catheters Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Drug Eluting Balloon Catheters Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Drug Eluting Balloon Catheters Market Drivers
12.2 Drug Eluting Balloon Catheters Market Restraints
12.3 Drug Eluting Balloon Catheters Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Drug Eluting Balloon Catheters and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drug Eluting Balloon Catheters
13.3 Drug Eluting Balloon Catheters Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Drug Eluting Balloon Catheters Typical Distributors
14.3 Drug Eluting Balloon Catheters Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Drug Eluting Balloon Catheters market size was valued at US$ 1564 million in 2025 and is forecast to a readjusted size of US$ 3556 million by 2032 with a CAGR of 12.3% during review period.
Drug eluting balloon catheters (DEB; commonly referred to as drug-coated balloon catheters, DCB) are percutaneous endovascular devices with an antiproliferative drug (typically paclitaxel or “limus” agents) and an excipient/carrier layer coated on the balloon surface. During angioplasty, the catheter delivers both mechanical luminal gain and rapid, targeted drug transfer into the vessel wall to suppress neointimal hyperplasia and reduce restenosis—while embracing a “leave nothing behind” strategy that avoids permanent implants and their long-term inflammatory/thrombotic burden. DEB/DCB catheters are used across PAD, dialysis access maintenance, and selected coronary scenarios such as in-stent restenosis and small-vessel disease, increasingly integrated with lesion preparation and intravascular imaging to enable more refined vascular repair.In 2025, global Drug eluting balloon catheters production reached approximately1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Drug eluting balloon catheters are benefiting from a structural shift “from implantation to repair” and “from single devices to integrated solutions.” On the regulatory front, the U.S. FDA’s updated assessment on paclitaxel-coated devices for PAD has provided a clearer risk boundary, making hospital governance and clinical pathway adoption more actionable. Meanwhile, leading multinationals continue to highlight DCB portfolios and their commercial traction in annual reporting, signaling rising strategic weight within peripheral and broader cardiovascular franchises. With expanding indications, iterative improvements in coating/excipient systems and drug-transfer performance, and accumulating real-world evidence, DEB/DCB catheters are moving from an “adjunct option” toward a more standardized tool set that can scale across centers.
Competition has shifted from “can you build it” to “can you scale it with compliance and reproducibility.” In China, national-level communications and public notices on centralized volume-based procurement and winning results have been released, accelerating a market phase defined by price constraints, supply assurance, and quality systems. Brokerage commentary broadly notes that procurement reforms can standardize purchasing and usage and improve market order, but near-term price pressure may compress margins—forcing manufacturers to rebuild value through yield improvement, scaled manufacturing, and differentiated clinical evidence. Globally, scrutiny on long-term outcomes and net clinical benefit will persist, making “evidence + risk management + manufacturing consistency” the three enduring pillars.
Downstream demand is moving toward bundled therapy: hospitals increasingly prioritize fewer reinterventions, shorter length of stay, and procedural efficiency—driving more routine combination of DEB/DCB with lesion preparation devices, specialty balloons, and intravascular imaging (IVUS/OCT). At the same time, broader national procurement coverage encourages centers to build repeatable, compliant standard-of-care pathways and device combinations, shifting growth from “operator preference–driven” to “pathway and discipline-building–driven.” For manufacturers, the next growth curve is less about a single catheter and more about delivering an adoptable clinical solution supported by evidence communication, training systems, and follow-up tools that reinforce customer stickiness.
Upstream value is defined not only by materials but by a controlled coating process chain and consistent batch release. Key inputs include balloon and catheter polymers (balloon films and multi-durometer shafts), drug APIs (paclitaxel or “limus” agents) and excipient/carrier systems, coating solvents and metrology consumables, sterile barrier packaging, and sterilization services. Under simultaneous procurement pressure and global compliance expectations, upstream partners must deliver medical-grade traceability, robust change control, and clean manufacturing. Any drift in drug crystallinity, excipient formulation, or coating process window can alter drug-transfer performance and batch stability—directly impacting clinical reputation and commercialization efficiency. In line with brokerage emphasis on “cost efficiency and supply assurance” as core competitive variables, deep upstream integration and platformized process capability are becoming decisive differentiators.
This report is a detailed and comprehensive analysis for global Drug Eluting Balloon Catheters market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Eluting Balloon Catheters market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Drug Eluting Balloon Catheters market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Drug Eluting Balloon Catheters market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Drug Eluting Balloon Catheters market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Eluting Balloon Catheters
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Eluting Balloon Catheters market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Drug Eluting Balloon Catheters market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Peripheral DEB
Coronary DEB
Market segment by Balloon Platform Mechanics
In-Stent Restenosi
De Novo
Small Vessel
Market segment by Application
Cardiac Catheterization Lab
Hospital
Other
Major players covered
B. Braun
Medtronic
Boston Scientific
BD
Yinyi Biotechnology
Acotec
Philips
Lepu Medical
Eurocor
MicroPort Medical
Teleflex
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Balloon Catheters product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug Eluting Balloon Catheters, with price, sales quantity, revenue, and global market share of Drug Eluting Balloon Catheters from 2021 to 2026.
Chapter 3, the Drug Eluting Balloon Catheters competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Balloon Catheters breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Drug Eluting Balloon Catheters market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Eluting Balloon Catheters.
Chapter 14 and 15, to describe Drug Eluting Balloon Catheters sales channel, distributors, customers, research findings and conclusion.

Buy now